Medtronic Cardiac Surgery PMCF Registry

Description

This registry is being conducted to support ongoing post-market surveillance activities.

Conditions

Valve Disease, Heart

Talk to us

Study Overview

On this page

Study Details

Study overview

This registry is being conducted to support ongoing post-market surveillance activities.

Medtronic Cardiac Surgery Post Market Clinical Follow-up Registry

Medtronic Cardiac Surgery PMCF Registry

Condition
Valve Disease, Heart
Intervention / Treatment

-

Contacts and Locations

Marietta

WellStar Kennestone Hospital, Marietta, Georgia, United States, 30060

Ann Arbor

University of Michigan, Ann Arbor, Michigan, United States, 48109

New York

Mount Sinai Medical Center, New York, New York, United States, 10029

Roslyn

Saint Francis Hospital, Roslyn, New York, United States, 11576

Syracuse

Saint Josephs Hospital Health Center, Syracuse, New York, United States, 13203

Durham

Duke University Medical Center, Durham, North Carolina, United States, 27710

Cleveland

University Hospitals Cleveland, Cleveland, Ohio, United States, 44106

Pittsburgh

University of Pittsburgh Medical Center UPMC Presbyterian, Pittsburgh, Pennsylvania, United States, 15213

Houston

Baylor St. Luke's Medical Center, Houston, Texas, United States, 77030

Plano

The Heart Hospital Plano, Plano, Texas, United States, 75093

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. Patient or legally authorized representative provides written authorization and/or consent per institution and geographical requirements
  • 2. Patient has or is intended to receive or be treated with an eligible product
  • 3. Patient is within enrollment window of treatment/therapy received at the time of their initial Registry enrollment, or meets criteria for retrospective enrollment
  • 1. Patient who is, or is expected to be, inaccessible for follow-up
  • 2. Patient prohibited from participation by local law
  • 3. Patient is currently enrolled in or plans to enroll in any concurrent investigational drug and/or device study that may confound results

Ages Eligible for Study

to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Medtronic Cardiac Surgery,

Study Record Dates

2039-12-31